Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2020American Journal of TransplantationOpen Access

Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement

View Full Paper
Ask AI
Bookmark
Share

Authors

DADavid Al‐AdraLHLaura L. HammelJRJohn P. Roberts

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Al‐Adra et al. (2020) studied this question.

synapsesocial.com/papers/69d73d248e958094d1b8a668https://doi.org/10.1111/ajt.16324
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma2019 · 1,411 citations
  2. 2Overall and Cause-Specific Mortality in Transplant Recipients with a Pretransplantation Cancer History2013 · 86 citations
  3. 3Acute Rejection, T-Cell–Depleting Antibodies, and Cancer After Transplantation2014 · 72 citations
  4. 4Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma2018 · 256 citations